RT @BioAgilytix: #DYK female breast cancer is the 2nd leading cause of death in the overall burden of cancers worldwide? Discover the advan…
#DYK female breast cancer is the 2nd leading cause of death in the overall burden of cancers worldwide? Discover the advances done in the era of #biomarker studies and their link in supporting #breastcancer #immunotherapy. https://t.co/AhVlSuPT58 https://t
Read this informative mini-review on I/O biomarkers to learn about the current state of liquid and tumor biopsies and future challenges #liquidbiopsy #tumorbiopsy https://t.co/Z1ko7tVfsm https://t.co/8BvzEKtefR
New Research: Immuno-Oncology Biomarkers for Personalized Immunotherapy in Breast Cancer: The immune checkpoint blockade therapy has drastically advanced treatment of different types of cancer over the past few years. Female breast cancer is… https://t.co/